Vidaza and white blood cell count decreased Patient Reports February 11, 2012

Vidaza Side Effects Report #4599482-4
Vidaza side effect was reported by a Physician from on Feb 16, 2005. Female patient, 78 years of age, weighting 85.00 lb, was diagnosed with refractory anaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: platelet count increased, respiratory distress, white blood cell count decreased. Vidaza dosage: 106 MG, DAILY X 7 DAYS (SKIP SAT + SUN)), SUBCUTANEOUS. During the same period patient was treated with ANZAMET, ALOXI, PLAVIX, NORVASC, CLARITIN, BUTISOL, VITAMIN B. Patient died on 02/12/2005.

Vidaza Side Effects Report #4635665-2
Vidaza side effect was reported by a Physician from on Mar 31, 2005. Female patient, 83 years of age, weighting 118.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agitation, anaemia, coma, gastrointestinal haemorrhage, myoclonus, neuropathy, thrombocytopenia, white blood cell count decreased. Vidaza dosage: 115 MG, SUBCUTAENOUS. During the same period patient was treated with THALOMID, VERAPAMIL, ASPIRIN, DILANTIN, OCUVITE, ZANTAC, PULMICORT, ATROVENT. Patient was hospitalized. Patient died on 11/30/2004.

Vidaza Side Effects Report #4949686-3
Vidaza side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 79 years of age, weighting 188.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, blood pressure decreased, dyspnoea, haemoglobin decreased, pneumonia , tremor, white blood cell count decreased. Vidaza dosage: 50 MG/M2 (100 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, FUROSEMIDE, VALSARTAN, LANSOPRAZOLE. Patient was hospitalized. Patient died on 01/25/2006.

Vidaza Side Effects Report #5897622-8
Vidaza side effect was reported by a Physician from GERMANY on Sept 09, 2008. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: gingival bleeding, glossodynia, hypersensitivity, neutrophil count decreased, salivary hypersecretion, white blood cell count decreased. Vidaza dosage: (75 MG/M2), INTRAVENOUS. During the same period patient was treated with CHLORIDE, ONDANSETRON, LEVOFLOXACIN, AMLODIPINE, ENALAPRIL MALEATE, BISOPROLOL FUMARATE, POTASSIUM SALT, FUROSEMIDE. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5906773-0
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 19, 2008. Male patient, 65 years of age, weighting 167.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pyrexia, tenosynovitis, white blood cell count decreased. Vidaza dosage: (75 MG/M2) ,SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE, AMLODIPINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4773089-8
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 01, 2005. Male patient, 64 years of age, weighting 157.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, platelet count decreased, pneumonia , white blood cell count decreased. Vidaza dosage: unknown. During the same period patient was treated with PROCRIT, CARDIZEM, LASIX. Patient was hospitalized. Patient died on 07/31/2005.

Vidaza Side Effects Report #5897620-4
Vidaza side effect was reported by a Physician from GERMANY on Sept 09, 2008. Male patient, 45 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bite, dysphagia, hypersensitivity, neutrophil count decreased, sepsis , soft tissue infection, swollen tongue, white blood cell count decreased. Vidaza dosage: (75 MG/M2), INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, ELECTROLYTES, ONDANSETRON, CEFTAZIDIM, PANTOPRAZOLE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5918529-3
Vidaza side effect was reported by a Consumer or non-health professional from GERMANY on Sept 24, 2008. Male patient, 45 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: dysphagia, intentional self-injury, neutrophil count decreased, white blood cell count decreased. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, ELECTROLYTES, ONDANSETRON, CEFTAZIDIM, PANTOPRAZOLE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #6023993-8
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 24, 2008. Male patient, weighting 167.1 lb, was diagnosed with myelodysplastic syndrome, pancytopenia, depression , pain  and was treated with Vidaza. After drug was administered, patient experienced the following side effects: febrile neutropenia, myelodysplastic syndrome, neutrophil count decreased, pneumonia , pneumonitis, thrombocytopenia, white blood cell count decreased. Vidaza dosage: unknown. During the same period patient was treated with RED BLOOD CELL TRANSFUSION, PRILOSEC, SENOKOT, ZOLOFT, VICODIN, HYDROXYZINE. Patient was hospitalized. Patient died on 10/07/2008.


Vidaza Side Effects Report #5804541-1
Vidaza side effect was reported by a Physician from GERMANY on June 24, 2008. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: lung infiltration, neutropenia, respiratory failure, white blood cell count decreased. Vidaza dosage: (143 MG, 5 D, SUBCUTANEOUS). Patient was hospitalized. Patient died on 06/17/2008.

Vidaza Side Effects Report #5343436-7
Vidaza side effect was reported by a Physician from UNITED KINGDOM on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. Vidaza dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.

Vidaza Side Effects Report #6082950-6
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Male patient, weighting 167.1 lb, was diagnosed with pancytopenia, depression , pain  and was treated with Vidaza. After drug was administered, patient experienced the following side effects: febrile neutropenia, myelodysplastic syndrome, neutrophil count decreased, pneumonia , pneumonitis, thrombocytopenia, white blood cell count decreased. Vidaza dosage: unknown. During the same period patient was treated with RED BLOOD CELL TRANSFUSION, PRILOSEC, SENOKOT, ZOLOFT, VICODIN, HYDROXYZINE. Patient was hospitalized. Patient died on 10/07/2008.